Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis?
about
Strategies to Optimize Adult Stem Cell Therapy for Tissue RegenerationDexamethasone and azathioprine promote cytoskeletal changes and affect mesenchymal stem cell migratory behaviorIntraperitoneal injection (IP), Intravenous injection (IV) or anal injection (AI)? Best way for mesenchymal stem cells transplantation for colitisMesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin woundsSafety and therapeutic effect of mesenchymal stem cell infusion on moderate to severe ulcerative colitis.Effect of mesenchymal stem cells on small intestinal injury in a rat model of acute necrotizing pancreatitis.Mesenchymal Stem Cells of Dental Origin-Their Potential for Antiinflammatory and Regenerative Actions in Brain and Gut Damage.Cryopreserved IL-4-treated macrophages attenuate murine colitis in an integrin β7-dependent mannerMembrane particles generated from mesenchymal stromal cells modulate immune responses by selective targeting of pro-inflammatory monocytes.Repeated systemic administration of adipose tissue-derived mesenchymal stem cells prevents tracheal obliteration in a murine model of bronchiolitis obliterans.Antioxidant properties of mesenchymal stem cells against oxidative stress in a murine model of colitis.Endoscopic submucosal injection of adipose-derived mesenchymal stem cells ameliorates TNBS-induced colitis in rats and prevents stenosis.Temporal clinical, proteomic, histological and cellular immune responses of dextran sulfate sodium-induced acute colitis
P2860
Q26747501-44C1467D-25B5-4DC0-85B2-B33FFD91E324Q27311400-1ACF23DC-6EF7-4A2C-B693-6E700CC32145Q27321287-7797A30D-8909-4A3E-9E09-FB52EA9E830CQ28085040-D2D7B098-AD6F-409F-B960-9AA9533837F3Q37406435-C7CF4143-4E66-4AF1-8C49-DEBD7EC6C7FBQ37602646-4A1BED77-2F53-4F30-BCA8-C926F8A6C848Q37677012-4142E243-4657-4A7A-AECA-6A18B91172FEQ39800349-E41CB18F-EC6C-4151-867E-F1E4B744B44DQ42362354-47DD88D7-3B88-43B4-997B-70F2682C8095Q52867314-1ACF3DB7-BBB9-471F-AAE9-48306AFF44BDQ52935391-2CF1D77C-DFC7-4DC3-BE00-C80619E371A3Q55023140-FAB565F0-87E2-47A8-AA70-F9243D78BB06Q57815111-AEA9321A-AFA0-4008-939E-331C9A4C5E2C
P2860
Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis?
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Intravenous vs intraperitoneal ...... treating experimental colitis?
@ast
Intravenous vs intraperitoneal ...... treating experimental colitis?
@en
Intravenous vs intraperitoneal ...... treating experimental colitis?
@nl
type
label
Intravenous vs intraperitoneal ...... treating experimental colitis?
@ast
Intravenous vs intraperitoneal ...... treating experimental colitis?
@en
Intravenous vs intraperitoneal ...... treating experimental colitis?
@nl
prefLabel
Intravenous vs intraperitoneal ...... treating experimental colitis?
@ast
Intravenous vs intraperitoneal ...... treating experimental colitis?
@en
Intravenous vs intraperitoneal ...... treating experimental colitis?
@nl
P2093
P2860
P1476
Intravenous vs intraperitoneal ...... treating experimental colitis?
@en
P2093
Ana Helena Paz
Eduardo Pandolfi Passos
Elizabeth Obino Cirne-Lima
Fabiany da Costa Gonçalves
Fabíola Schons Meyer
Fernanda Otesbelgue Pinto
Fernanda Visioli
Luíse Meurer
Natália Schneider
Patrícia Luciana da Costa Lopez
P2860
P304
18228-18239
P356
10.3748/WJG.V20.I48.18228
P407
P577
2014-12-01T00:00:00Z